Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 5, 2018 at 12:45 PM EDT

Wedbush’s Monday ASCO Roundup

The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant…

Chris Lange | Jun 5, 2018 at 10:05 AM EDT

How Deciphera Pharma Is Capitalizing Big on ASCO

Deciphera Pharmaceuticals saw its shares took a breather early Tuesday after the firm announced a secondary offering.

Chris Lange | Jun 5, 2018 at 8:40 AM EDT

Mylan Wins Big With FDA Approval

Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila…

Chris Lange | Jun 4, 2018 at 1:00 PM EDT

Jounce Therapeutics Sinks on ASCO Update

Jounce Therapeutics watched its shares drop sharply on Monday after the company presented preliminary data from its early stage cancer…

Chris Lange | Jun 4, 2018 at 10:45 AM EDT

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from…

Lee Jackson | Jun 4, 2018 at 10:05 AM EDT

Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference

While the health care sector as a whole has had its ups and downs, there is no question that mergers…

Lee Jackson | Jun 1, 2018 at 10:30 AM EDT

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

It’s no surprise that it was only a matter of time before the usage and storage of big data and…

Chris Lange | May 31, 2018 at 11:45 AM EDT

Why Positive Results Just Aren’t Good Enough for Clearside Bio

Clearside Biomedical shares were dropping early on Thursday after the company released data from its midstage clinical trial of Eylea…

Chris Lange | May 31, 2018 at 9:10 AM EDT

How Newsoara Bio Is Saving vTv Therapeutics

vTv Therapeutics watched its shares make a massive gain early on Thursday after the firm announced an exclusive licensing agreement…

Chris Lange | May 31, 2018 at 8:35 AM EDT

CRISPR Faces FDA Clinical Hold

CRISPR Therapeutics shares saw a significant drop on Thursday morning after an announcement that the FDA placed a clinical hold…

Chris Lange | May 30, 2018 at 11:45 AM EDT

How Immutep Is Making Waves With Its Keytruda Combination

Immutep shares saw a nice gain in Wednesday’s session after the company released new data from its early-stage clinical trial…

Douglas A. McIntyre | May 30, 2018 at 6:25 AM EDT

Hospital Launches Rehab for Cryptocurrency Traders

It was only a matter of time before cryptocurrency traders, who often sit at their trading desks for long hours…

Chris Lange | May 29, 2018 at 8:35 AM EDT

Meet Pfizer’s Newest FDA Designations

Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).

Chris Lange | May 25, 2018 at 9:40 AM EDT

Short Interest Remains Mixed in Major Biotechs

The May 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 131 132 133 134 135 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Wedbush’s Monday ASCO Roundup

How Deciphera Pharma Is Capitalizing Big on ASCO

Mylan Wins Big With FDA Approval

Jounce Therapeutics Sinks on ASCO Update

Why Nektar Therapeutics Shares Are Tumbling

Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Why Positive Results Just Aren’t Good Enough for Clearside Bio

How Newsoara Bio Is Saving vTv Therapeutics

CRISPR Faces FDA Clinical Hold

How Immutep Is Making Waves With Its Keytruda Combination

Hospital Launches Rehab for Cryptocurrency Traders

Meet Pfizer’s Newest FDA Designations

Short Interest Remains Mixed in Major Biotechs

Major Pharma Short Sellers Grow More Selective

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Wedbush’s Monday ASCO Roundup

How Deciphera Pharma Is Capitalizing Big on ASCO

Mylan Wins Big With FDA Approval

Jounce Therapeutics Sinks on ASCO Update

Why Nektar Therapeutics Shares Are Tumbling

Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Why Positive Results Just Aren’t Good Enough for Clearside Bio

How Newsoara Bio Is Saving vTv Therapeutics

CRISPR Faces FDA Clinical Hold

How Immutep Is Making Waves With Its Keytruda Combination

Hospital Launches Rehab for Cryptocurrency Traders

Meet Pfizer’s Newest FDA Designations

Short Interest Remains Mixed in Major Biotechs

Major Pharma Short Sellers Grow More Selective

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how